Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16.
Smith
M A
MA
University Department of Haematology, Western Infirmary, Glasgow, UK.
Merry
S
S
Smith
J G
JG
Kaye
S B
SB
D001853:Bone Marrow / Q000187:drug effects*; D001854:Bone Marrow Cells; D003114:Colony-Forming Units Assay; D004317:Doxorubicin / Q000494:pharmacology*; D004357:Drug Synergism; D005047:Etoposide / Q000494:pharmacology*; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D014700:Verapamil / Q000008:administration & dosage / Q000494:pharmacology*
D005047:Etoposide; D004317:Doxorubicin; D014700:Verapamil